EMBOTRAP II Revascularization Device
Total Payments
$5.4M
Transactions
2,427
Doctors
652
Companies
4
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $2.3M | 1,139 | 369 |
| 2019 | $3.0M | 948 | 368 |
| 2018 | $67,197 | 340 | 164 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $4.8M | 326 | 88.6% |
| Consulting Fee | $506,292 | 143 | 9.4% |
| Food and Beverage | $85,447 | 1,932 | 1.6% |
| Travel and Lodging | $20,406 | 26 | 0.4% |
Payments by Type
Research
$4.8M
326 transactions
General
$612,145
2,101 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Embotrap extraction & Clot Evaluation & Lesion Evaluation for Neurothrombectomy | Medical Device Business Services, Inc. | $1.9M | 0 |
| ENDOLOW Endovascular Therapy for low NIHSS Ischemic Strokes | Medical Device Business Services, Inc. | $1.4M | 0 |
| EmboTrap Revascularization Device CNV_2017_02 Embotrap extraction & Clot EvaLuation & Lesion Evaluation for NeuroThrombectomy or EXCELLENT Registry | Medical Device Business Services, Inc. | $1.0M | 0 |
| TESLA - Thrombectomy for emergent salvage of large anterior circulation ischemic stroke | Medical Device Business Services, Inc. | $288,750 | 0 |
| Excellent Registry | Medical Device Business Services, Inc. | $147,486 | 0 |
| ARISE II (Analysis of Revasularization in Ischemic Stroke with EmboTrap) | Medical Device Business Services, Inc. | $20,275 | 1 |
| EmboTrap Revascularization Device according to Protocol CNV_2017_02 entitled Embotrap eXtraction & Clot EvaLuation & Lesion Evaluation for NeuroThrombectomy or EXCELLENT Registry | Medical Device Business Services, Inc. | $12,700 | 0 |
Top Doctors Receiving Payments for EMBOTRAP II Revascularization Device
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Jacksonville, FL | $4.7M | 325 |
| , MD | Vascular Neurology | Toledo, OH | $103,599 | 37 |
| , M.D | Neurological Surgery | Orlando, FL | $62,400 | 6 |
| , MD, PHD | Neurological Surgery | Buffalo, NY | $49,790 | 29 |
| , MD | Diagnostic Radiology | Washington, DC | $43,837 | 23 |
| , MD | Neurology | Boston, MA | $24,805 | 14 |
| , MD | Neurological Surgery | Los Angeles, CA | $21,088 | 6 |
| , M.D | Neurology | Nashville, TN | $18,750 | 5 |
| , MD | Neuroradiology | Boston, MA | $18,482 | 14 |
| , MD | Vascular Neurology | Marietta, GA | $18,402 | 18 |
| , M.D | Neuroradiology | Morgantown, WV | $16,736 | 22 |
| , M.D | Vascular & Interventional Radiology | Fullerton, CA | $16,090 | 8 |
| , MD | Neurological Surgery | Salt Lake City, UT | $13,137 | 12 |
| , MD | Neurological Surgery | Memphis, TN | $12,328 | 6 |
| , M.D., PHD | Neurological Surgery | Jacksonville, FL | $11,549 | 10 |
| , MD | Neurological Surgery | Los Angeles, CA | $9,949 | 18 |
| , MD | Neurological Surgery | New York, NY | $9,117 | 2 |
| , M.D | Neurological Surgery | San Antonio, TX | $9,023 | 14 |
| , MD | Neurological Surgery | Miami, FL | $8,548 | 5 |
| , MD | Neurology | Pittsburgh, PA | $8,146 | 8 |
| , MD | Vascular Neurology | Cleveland, OH | $7,250 | 6 |
| , MD | Neuroradiology | Indianapolis, IN | $7,081 | 12 |
| , MD | Diagnostic Radiology | Chattanooga, TN | $6,655 | 7 |
| , MD | Vascular & Interventional Radiology | Knoxville, TN | $6,031 | 4 |
| , DO | Vascular Neurology | Harlingen, TX | $5,693 | 13 |
Ad
Manufacturing Companies
- Medical Device Business Services, Inc. $5.3M
- DePuy Synthes Sales Inc. $74,040
- Biosense Webster, Inc. $2,148
- DePuy Synthes Products, Inc. $160.61
Product Information
- Type Device
- Total Payments $5.4M
- Total Doctors 652
- Transactions 2,427
About EMBOTRAP II Revascularization Device
EMBOTRAP II Revascularization Device is a device associated with $5.4M in payments to 652 healthcare providers, recorded across 2,427 transactions in the CMS Open Payments database. The primary manufacturer is Medical Device Business Services, Inc..
Payment data is available from 2018 to 2020. In 2020, $2.3M was paid across 1,139 transactions to 369 doctors.
The most common payment nature for EMBOTRAP II Revascularization Device is "Unspecified" ($4.8M, 88.6% of total).
EMBOTRAP II Revascularization Device is associated with 7 research studies, including "Embotrap extraction & Clot Evaluation & Lesion Evaluation for Neurothrombectomy" ($1.9M).